Cite
HARVARD Citation
Liapis, V. et al. (n.d.). Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models. Cancer medicine. pp. 534-545. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liapis, V. et al. (n.d.). Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models. Cancer medicine. pp. 534-545. [Online].